EDGAR Filing Documents for 0001546927-15-000261

Form 3 - Initial statement of beneficial ownership of securities:

SEC Accession No. 0001546927-15-000261

Filing Date

2015-10-20

Accepted

2015-10-20 13:50:22

Documents

Period of Report

2015-10-15

Document Format Files

Seq	Description	Document	Type	Size
1	OWNERSHIP DOCUMENT	camberprotalxform3filed.html	3
1	OWNERSHIP DOCUMENT	camberprotalxform3filed.xml	3	5052
	Complete submission text file	0001546927-15-000261.txt		6899

Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100

Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488

Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 101 HUNTINGTON AVENUE SUITE 2550 BOSTON MA 02199

Business Address 101 HUNTINGTON AVENUE SUITE 2550 BOSTON MA 02199 617-717-6600

State of Incorp.: MA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-33357 | Film No.: 151166044